Clinical Trial Update: Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Lingzhi in patients with early Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lingzhi (Ganoderma lucidum extract)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED